NCT01779050 Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Status TERMINATED Phase PHASE2
NCT01777152 ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Status COMPLETED Phase PHASE3
NCT01775475 Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01762202 Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia. Status COMPLETED Phase PHASE2
NCT01760655 Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT01760226 Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies Status COMPLETED Phase EARLY_PHASE1
NCT01759732 Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia Status UNKNOWN Phase PHASE2
NCT01750073 Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01749293 Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation Status TERMINATED Phase PHASE2
NCT01746849 Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01740557 Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT01740401 CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma Status TERMINATED Phase PHASE2
NCT01731886 Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma Status COMPLETED Phase PHASE4
NCT01729338 Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma Status TERMINATED Phase PHASE2
NCT01724866 Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer Status COMPLETED Phase PHASE2
NCT01719835 CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study Status UNKNOWN Phase PHASE2
NCT01707004 Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT01706666 Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT01705691 Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer Status COMPLETED Phase PHASE2